loadpatents
name:-0.0094959735870361
name:-0.002824068069458
name:-0.0067839622497559
Heuck; Christoph Patent Filings

Heuck; Christoph

Patent Applications and Registrations

Patent applications and USPTO patent grants for Heuck; Christoph.The latest application filed is for "clinically proven subcutaneous pharmaceutical compositions comprising anti-cd38 antibodies and their uses".

Company Profile
7.2.9
  • Heuck; Christoph - Princeton NJ
  • HEUCK; Christoph - Little Rock AR
  • Heuck; Christoph - Litttle Rock AR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses
App 20220041745 - Bandekar; Rajesh ;   et al.
2022-02-10
Gep5 Model For Multiple Myeloma
App 20200392587 - BARLOGIE; Bart ;   et al.
2020-12-17
Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib, Mephalan and Prednisone
App 20200330593 - Bandekar; Rajesh ;   et al.
2020-10-22
Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib and Dexamethasone
App 20200316197 - Bandekar; Rajesh ;   et al.
2020-10-08
Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Lenalidomide and Dexamethasone
App 20200308284 - Bandekar; Rajesh ;   et al.
2020-10-01
Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses
App 20200308297 - Bandekar; Rajesh ;   et al.
2020-10-01
Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Pomalidomide and Dexamethasone
App 20200308296 - Bandekar; Rajesh ;   et al.
2020-10-01
GEP5 model for multiple myeloma
Grant 10,752,956 - Barlogie , et al. A
2020-08-25
Gep5 Model For Multiple Myeloma
App 20180171414 - Barlogie; Bart ;   et al.
2018-06-21
GEP5 model for multiple myeloma
Grant 9,822,419 - Barlogie , et al. November 21, 2
2017-11-21
Gep5 Model For Multiple Myeloma
App 20160102362 - BARLOGIE; Bart ;   et al.
2016-04-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed